Results 171 to 180 of about 5,473,832 (328)

Language on language

open access: yesIPrA Papers in Pragmatics, 2022
openaire   +1 more source

Maldivian Language [PDF]

open access: hybrid, 2020
National Cancer Institute
openalex   +1 more source

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li   +10 more
wiley   +1 more source

Submission Guidelines, 1(1)

open access: yesLanguage Documentation & Conservation, 2007
Language Documentation & Conservation
doaj   +1 more source

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli   +5 more
wiley   +1 more source

Editorial Board, 1(1)

open access: yesLanguage Documentation & Conservation, 2007
Language Documentation & Conservation
doaj   +1 more source

Quantifying the effect of air quality offsets on household air pollution and thermal comfort on the South Africa Highveld

open access: yesClean Air Journal, 2020
Joseph Adesina   +5 more
doaj   +1 more source

A 3.5-minute-long reading-based fMRI localizer for the language network. [PDF]

open access: yesImaging Neurosci (Camb)
Tuckute G, Lee EJ, Sathe A, Fedorenko E.
europepmc   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy